Skip to content
Screener

Rocket Pharmaceuticals RCKT Q3 2025 earnings

Reported November 6, 2025 · Before market open

EPS-$0.45Beat by $0.03
Revenue estimate$312.5K
EPS estimate-$0.48

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$200.0K
EPS estimate-$0.39

FAQ

When did Rocket Pharmaceuticals report Q3 2025 earnings?
Rocket Pharmaceuticals (RCKT) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Rocket Pharmaceuticals's Q3 2025 revenue and EPS?
Rocket Pharmaceuticals reported eps of $-0.45 for Q3 2025.
Did Rocket Pharmaceuticals beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.48 by $0.03.
How did Rocket Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 36.6% from $-0.71.
Where can I find Rocket Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001140361-25-040774) and the 10-Q periodic report (0001193125-25-269474) directly on SEC EDGAR. The filing index links above go to sec.gov.